Indivior PLC (INDV) | Stock Overview & Key Data
Indivior PLC Performance Comparison
Stock Range
Today's Range
Low: $24.03
High: $24.64
on August 22, 2025
52 Week Range
Low: $7.33
High: $24.64
on October 14, 2024
on August 22, 2025
All-Time High: $26.50 on June 12, 2023
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.9B
EPS
0.81
P/E Ratio (TTM)
28.99
Forward P/E
21.94
P/B Ratio
N/A
PEG Ratio
21.94
Div. Yield
N/A
ROE
-0.57%
Beta
0.959
Debt to Equity
-1.42
Financial Highlights
Profitability
Gross Margin
82.78%
Operating Margin
23.51%
Profit Margin
4.52%
Returns and Earnings
Return on Assets (TTM)
13.14%
Return on Equity (TTM)
-0.57%
EBITDA
$274.0M
Net Income (TTM)
$53.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$9.39
Quarterly Revenue Growth (YoY)
1.00%
Quarterly Earnings Growth (YoY)
1.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Indivior PLC INDV | 2.93B Mid-cap | 3.80% | 54.17% | 113.02% | 184.62% | 92.40% | 95.53% | 550.00% | 1,471.90% |
| Zoetis ZTS | 65.30B Large-cap | 4.59% | 0.82% | -3.89% | -1.51% | -5.23% | -16.11% | -9.09% | -2.69% |
| Haleon Plc - ADR HLN | 43.42B Large-cap | 1.13% | 2.94% | -11.62% | -2.68% | 3.92% | -0.91% | 57.46% | 32.39% |
| Elanco Animal Health ELAN | 8.70B Mid-cap | -2.83% | 19.14% | 38.59% | 58.71% | 45.15% | 20.04% | 13.72% | -39.96% |
| Regencell Bioscience RGC | 6.08B Mid-cap | -1.10% | -12.78% | 15.02% | 10,366.67% | 9,561.54% | 5,609.09% | 1,531.17% | 4,385.71% |
| Alkermes plc ALKS | 4.80B Mid-cap | 2.83% | 9.00% | -4.81% | -17.72% | 1.08% | 3.97% | 18.42% | 77.74% |
Ownership & Short Interest
Insider Ownership
3.88%
Institutional Ownership
95.43%
Shares Short
7M
Short Ratio
2.08
Short % of Shares Outstanding
5.76%
Average 10-Day Volume
2M
Average 90-Day Volume
4M
Indivior PLC Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Indivior PLC would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is INDV's 52-week high and low?
- In the last 52 weeks, Indivior PLC reached a high of $24.64 (on August 22, 2025) and a low of $7.33 (on October 14, 2024).
- What is the market cap and P/E ratio for INDV?
- Curious about Indivior PLC's size and valuation? Its market capitalization stands at 2.93B. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.99, and the forward P/E (looking ahead) is 21.94.
- Does INDV pay dividends? If so, what's the yield?
- As for dividends, Indivior PLC isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Indivior PLC's main competitors or similar companies to consider before investing?
When looking at Indivior PLC, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS65.30B Healthcare Drug Manufacturers - Specialty & Generic -16.11% -9.09% Haleon Plc - ADR
HLN43.42B Healthcare Drug Manufacturers - Specialty & Generic -0.91% 57.46% Elanco Animal Health
ELAN8.70B Healthcare Drug Manufacturers - Specialty & Generic 20.04% 13.72% Regencell Bioscience
RGC6.08B Healthcare Drug Manufacturers - Specialty & Generic 5,609.09% 1,531.17% Alkermes plc
ALKS4.80B Healthcare Drug Manufacturers - Specialty & Generic 3.97% 18.42% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Indivior PLC? (e.g., ROE, Debt/Equity)
- To get a sense of Indivior PLC's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -0.57%, the Debt to Equity ratio from the most recent quarter is -1.42, and its Gross Profit Margin stands at 82.78%.
- What is the recent revenue and earnings growth for INDV?
- Looking at Indivior PLC's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 1.00%, and quarterly earnings saw a YoY growth of 1.00%.
- How much of INDV stock is held by insiders and institutions?
- Wondering who owns Indivior PLC stock? Company insiders (like executives and directors) hold about 3.88% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 95.43%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.